Kerri Fitzgerald

DocwireNews

Only about half of surveyed physicians report discussing the cost of cancer&nbsp;<a href="https://www.docwirenews.com/docwire-pick/shortcomings-of-new-brca1-2-genetic-test-recommendations/">genomic testing</a> with patients, according to a study published in the Journal of the National Cancer Institute.Researchers identified 1,220 oncologists who participated in the 2017 National Survey of Precision Medicine in Cancer Treatment and reported discussing <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/new-genetic-sequencing-technology-bolsters-colon-cancer-research/">genomic testing</a> with their patients with cancer. They assessed associations between oncologist and practice characteristics and the frequency of cost discussions.Just half of respondents said they often discuss the likely costs of testing and related treatments, while 26.3% reported sometimes discussing costs, and 23.7% reported never or rarely discussing costs.<h2>Past experience influences cost discussions</h2>Oncologists were more likely (defined as &ldquo;sometimes&rdquo; and &ldquo;often&rdquo;) to discuss costs if they had trained in genomic testing (odds ratio [OR] = 2.09; 95% CI, 1.19-3.69) or worked in practices with electronic medical record (EMR) alerts for genomic tests (OR=2.22; 95% CI, 1.30-3.79). Other factors statistically significantly associated with more frequent cost discussions included treating solid tumors (rather than hematologic cancers), using next-generation sequencing gene panel tests, having higher patient volume, and working in practices with higher percentages of patients insured by Medicaid, or self-paid or uninsured.&ldquo;Interventions targeting modifiable oncologist and practice factors, such as training in genomic testing and use of EMR alerts, may help improve cost discussions about genomic testing and related treatments,&rdquo; the authors concluded.

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Patients Not Being Made Aware of Costs of Cancer Genomic Tests

Oncology

Only about half of surveyed physicians report discussing the cost of cancer genomic testing with patients, according to a study published in the Journal of the National ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe